Expertise

John Arnott’s research focuses on the molecular signaling mechanisms in osteoblasts that regulate bone formation and fracture repair. His work aims to understand how bone growth factors—particularly connective tissue growth factor (CTGF/CCN2)—control osteoblast differentiation and function, as well as how CTGF expression is regulated by other signaling pathways. By elucidating the cellular and molecular processes underlying skeletal development and bone formation, his research seeks to identify potential therapeutic targets for enhancing bone regeneration and treating clinically significant bone loss, including osteoporosis.

Organizational Affiliations

Medical Education, Geisinger College of Health Sciences, Geisinger

Education

University of Scranton / Scranton, PA
BS (Bachelor of Science)

Undergraduate

Anatomy and Cell Biology
PhD (Doctor of Philosophy), Temple University Lewis Katz School of Medicine / Philadelphia, PA

Graduate

Business Administration
Temple University / Philadelphia, PA

Certificate